Placenta-on-a-chip

National Institutes of Health (NIH) researchers and their colleagues have developed a "placenta-on-a-chip" to study the inner workings of the human placenta and its role in pregnancy.

Studying the placenta in humans is challenging: it is time-consuming, subject...
Studying the placenta in humans is challenging: it is time-consuming, subject to a great deal of variability and potentially risky for the Fetus.
Source: panthermedia.net/wtolenaars

The device was designed to imitate, on a micro-level, the structure and function of the placenta and model the transfer of nutrients from mother to fetus. This prototype is one of the latest in a series of organ-on-a-chip technologies developed to accelerate biomedical advances.

The study, published online in the Journal of Maternal-Fetal & Neonatal Medicine, was conducted by an interdisciplinary team of researchers from the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the University of Pennsylvania, Wayne State University/Detroit Medical Center, Seoul National University and Asan Medical Center in South Korea.

"We believe that this technology may be used to address questions that are difficult to answer with current placenta model systems and help enable research on pregnancy and its complications," said Roberto Romero, M.D., chief of the NICHD's Perinatology Research Branch and one of the study authors.

The placenta is a temporary organ that develops in pregnancy and is the major interface between mother and fetus. Among its many functions is to serve as a "crossing guard" for substances traveling between mother and fetus. The placenta helps nutrients and oxygen move to the fetus and helps waste products move away. At the same time, the placenta tries to stop harmful environmental exposures, like bacteria, viruses and certain medications, from reaching the fetus. When the placenta doesn't function correctly, the health of both mom and baby suffers.

Researchers are trying to learn how the placenta manages all this traffic, transporting some substances and blocking others. This knowledge may one day help clinicians better assess placental health and ultimately improve pregnancy outcomes.

However, studying the placenta in humans is challenging: it is time-consuming, subject to a great deal of variability and potentially risky for the fetus. For those reasons, previous studies on placental transport have relied largely on animal models and on laboratory-grown human cells. These methods have yielded helpful information, but are limited as to how well they can mimic physiological processes in humans.

The researchers created the placenta-on-a-chip technology to address these challenges, using human cells in a structure that more closely resembles the placenta's maternal-fetal barrier. The device consists of a semi-permeable membrane between two tiny chambers, one filled with maternal cells derived from a delivered placenta and the other filled with fetal cells derived from an umbilical cord.

After designing the structure of the model, the researchers tested its function by evaluating the transfer of glucose (a substance made by the body when converting carbohydrates to energy) from the maternal compartment to the fetal compartment. The successful transfer of glucose in the device mirrored what occurs in the body.

"The chip may allow us to do experiments more efficiently and at a lower cost than animal studies," said Dr. Romero. "With further improvements, we hope this technology may lead to better understanding of normal placental processes and placental disorders."

Source: NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development

19.06.2015

Read all latest stories

Related articles

Photo

News • Driving genes of AMR in focus

Tracking the global spread of antimicrobial resistance

An international research team has provided valuable new information about what drives the global spread of genes responsible for antimicrobial resistance (AMR) in bacteria.

Photo

News • Lung adenocarcinoma

Therapeutic target against common lung cancer identified

A new study led by researchers in Barcelona has determined the protein TIMP-1 as a valuable biomarker for the progression of lung adenocarcinoma. The results open the door to new treatments.

Photo

News • Macrophages

Hunting for immune cells that predispose people to severe Covid-19

When a virus makes its way into the body, one of the immune system’s first responders is a set of pathogen-removal cells called macrophages. But they don’t all target viruses in the same way.

Related products

Medat – Laboratory Information System

LIS, Middleware, POCT

Medat – Laboratory Information System

Medat Computersysteme GmbH
Mesalvo – LabCentre

LIS, Middleware, POCT

Mesalvo – LabCentre

Mesalvo Mannheim GmbH (ehemals i-SOLUTIONS Health GmbH)
Shimadzu – LCMS-8060NX CL (IVD) / LCMS-8060 NX (RUO)

Mass Spectrometry

Shimadzu – LCMS-8060NX CL (IVD) / LCMS-8060 NX (RUO)

Shimadzu Europa GmbH
Siemens Healthineers · teamplay Images

Portal Solutions

Siemens Healthineers · teamplay Images

Siemens Healthineers
Agfa HealthCare · Dose Monitoring System

Dose Management Systems

Agfa HealthCare · Dose Monitoring System

Agfa HealthCare
Subscribe to Newsletter